相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Histopathologic variables predict Oncotype DX™ Recurrence Score
Melina B. Flanagan et al.
MODERN PATHOLOGY (2008)
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akin Akinc et al.
NATURE BIOTECHNOLOGY (2008)
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
Christine Desmedt et al.
CLINICAL CANCER RESEARCH (2007)
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
E. de Azambuja et al.
BRITISH JOURNAL OF CANCER (2007)
HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer:: A retrospective study
Maurice P. H. M. Jansen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer
Mitch Dowsett et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
The HOXB13:IL7BR expression index is a prognostic factor in early-stage breast cancer
Xiao-Jun Ma et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
Marc Buyse et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Concordance among gene-expression-based predictors for breast cancer
Cheng Fan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
Soonmyung Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer
JA Foekens et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen
MP Goetz et al.
CLINICAL CANCER RESEARCH (2006)
Prospects of RNA interference therapy for cancer
SI Pai et al.
GENE THERAPY (2006)
Prediction by supervised principal components
E Bair et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2006)
Ki-67 expression in operable breast cancer: A comparative study of immunostaining and a real-time RT-PCR assay
Piotr Potemski et al.
PATHOLOGY RESEARCH AND PRACTICE (2006)
siRNA-based approaches in cancer therapy
G. R. Devi
CANCER GENE THERAPY (2006)
Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer
Russell Burcombe et al.
BREAST CANCER RESEARCH (2006)
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
M Colozza et al.
ANNALS OF ONCOLOGY (2005)
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
LD Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients
HY Dai et al.
CANCER RESEARCH (2005)
Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy
FJ Esteva et al.
CLINICAL CANCER RESEARCH (2005)
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival
HY Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death
PH Tan et al.
MODERN PATHOLOGY (2005)
Semi-supervised methods to predict patient survival from gene expression data
E Bair et al.
PLOS BIOLOGY (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Good Old clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers
P Edén et al.
EUROPEAN JOURNAL OF CANCER (2004)
Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy
A Vincent-Salomon et al.
EUROPEAN JOURNAL OF CANCER (2004)
Pathological features of breast cancer response following neoadjuvant treatment with either letrozole or tamoxifen
WR Miller et al.
EUROPEAN JOURNAL OF CANCER (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Predicting the clinical status of human breast cancer by using gene expression profiles
M West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Missing value estimation methods for DNA microarrays
O Troyanskaya et al.
BIOINFORMATICS (2001)
Time-dependent ROC curves for censored survival data and a diagnostic marker
PJ Heagerty et al.
BIOMETRICS (2000)
Transcript imaging of the development of human T helper cells using oligonucleotide arrays
L Rogge et al.
NATURE GENETICS (2000)
分享论文
